New York Post: J&J’s ketamine-derived nasal spray approved by FDA to treat depression The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a standalone ...
Yahoo: FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment The U.S. Food and Drug Administration approved Johnson & Johnson‘s ketamine-based nasal spray as a standalone therapy for adults with treatment-resistant depression. The spray, Spravato, first ... PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression.
ketamine nasal spray what to expect, The hallucinogenic drug is an option when traditional treatment isn’t ... Fast Company: Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ... Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings Gizmodo: Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
ketamine nasal spray what to expect, Live Science: FDA approves ketamine-like nasal spray for depression — here's everything you need to know A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means. When you purchase ... FDA approves ketamine-like nasal spray for depression — here's everything you need to know Johnson & Johnson medication Spravato, a ketamine-based nasal spray, was approved Tuesday by the Food and Drug Administration for use as a sole treatment for depression. Spravato was first approved by ... Fox Business: J&J's ketamine-derived nasal spray approved by FDA to treat depression The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S.
patients suffering from severe depression. Spravato, approved as a standalone ...
